What is Acutis Diagnostics?
Acutis Diagnostics operates as a specialized clinical laboratory, concentrating on advanced PCR testing for a spectrum of infectious diseases, including urinary tract infections, alongside comprehensive toxicology lab services. The company is dedicated to serving medical providers and biopharmaceutical partners by delivering rapid turnaround times and sophisticated diagnostic capabilities. Leveraging cutting-edge technology and automation, Acutis Diagnostics aims to enhance patient care by providing precise and actionable data, thereby empowering healthcare professionals to make more informed clinical decisions through reliable testing and insightful analysis.
How much funding has Acutis Diagnostics raised?
Acutis Diagnostics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Acutis Diagnostics
PPP
Public-Private Partnership
What's next for Acutis Diagnostics?
The recent major strategic investment into Acutis Diagnostics, following its substantial total funding of $1M, positions the company for significant expansion and technological advancement. This capital infusion is expected to fuel further development of its PCR testing platforms and toxicology services, potentially broadening its market reach within the healthcare and biopharma sectors. Acutis Diagnostics is poised to enhance its operational capacity and solidify its standing as a key provider of rapid, accurate diagnostic solutions, driving innovation in clinical laboratory services.
See full Acutis Diagnostics company page
